STOCKHOLM, Sweden, May 30, 2005 (PRIMEZONE) --
INVITATION Stockholm, May 30, 2005 Elekta will release its year-end report for fiscal year 2004/05 on: - Wednesday, June 15, 2005, around 1 pm CET.
Elekta has the pleasure to invite investors, analysts and media to a Capital Markets Day the following day on June 16 from 2 pm to approx. 5 pm.
This event will be held at Elekta's head office on Kungstensgatan 18, in central Stockholm. Speakers will include Tomas Puusepp, President and CEO of Elekta AB, Joseph K Jachinowski, CEO of IMPAC Medical Systems, Inc and Hakan Bergstrom, CFO of Elekta.
If you plan to participate in person, please send an e-mail to ir@elekta.com.
The June 16 CMD will be broadcasted over the Internet (audio and slides). Please visit http://www.elekta.com/investors and follow the link or use the direct link: http://events.webeventservices.com/elekta/2 005/06/16/
It is also possible to dial in and listen to this event: - Swedish dial-in number: +46 (0)8 505 20 114 - UK dial-in number: +44 (0) 20 7162 0180 - US dial-in number: +1 334 323 6203 Password: Elekta (NOTE: for Local Connect dial-in numbers -- you must always dial the area code to enter the conference.)
Dial-in participants can watch slides on the web (see link above).
No telephone Q&A session will be held. Remote participants can instead e-mail questions to ir@elekta.com during the event.
The slide package will be distributed upon request after the event. If you wish to receive the slides, please send an e-mail to ir@elekta.com.
A replay of the event will be available until June 23, 2005. Please use the same link as above or call: - Swedish replay number: +46 (0)8 505 203 33 - UK replay number: +44 (0) 207 031 4064 - US replay number: +1 954 334 0342 Access code: 660707
We look forward to seeing you on June 16!
Best regards,
Peter Ejemyr Group VP Corporate Communications, Elekta AB Tel. +46 733 611 000, e-mail: peter.ejemyr@elekta.com
About Elekta
Elekta is an international medical-technology Group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta's solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective.
Clinical solutions include among others Leksell Gamma Knife(R) for non-invasive treatment of brain disorders and Elekta Synergy(R) for image guided radiation therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April 2005, The Elekta Group is the world's largest supplier of oncology software.
Elekta's systems and solutions are used in over 3,000 hospitals around the world to treat cancer and to manage clinical operations as well as to diagnose and treat brain disorders, including tumors, vascular malformations and functional disorders.
With approx. 1700 employees, Elekta's corporate headquarter is located in Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange under the ticker EKTAb.
This information was brought to you by Waymaker.
The following files are available for download:
http://wpy.waymaker.net/client/waymaker1/WOLReleaseFile.aspx?id=103164&fn=wkr0010.pdf PDF version